Showing 341-360 of 640 for: Cochrane Systematic Reviews > Cardiovascular 
- Interventions for treating brain arteriovenous malformations in adults
Cochrane Systematic Reviews, 10-Sep-2019
Brain arteriovenous malformations (AVMs) are the single most common cause of intracerebral haemorrhage in young adults. Brain AVMs also cause seizure(s) and focal neurological deficits (in the absence of haemorrhage, migraine or an epileptic seizure); app
- Interventions for treating tuberculous pericarditis
Cochrane Systematic Reviews, 13-Sep-2017
Tuberculous pericarditis can impair the heart's function and cause death; long term, it can cause the membrane to fibrose and constrict causing heart failure. In addition to antituberculous chemotherapy, treatments include corticosteroids, drainage, and s
- Interventions for treating urinary incontinence after stroke in adults
Cochrane Systematic Reviews, 1-Feb-2019
Urinary incontinence can affect 40% to 60% of people admitted to hospital after a stroke, with 25% still having problems when discharged from hospital and 15% remaining incontinent after one year.
- Interventions for varicose veins and leg oedema in pregnancy
Cochrane Systematic Reviews, 19-Oct-2015
Pregnancy is presumed to be a major contributory factor in the increased incidence of varicose veins in women, which can in turn lead to venous insufficiency and leg oedema. The most common symptom of varicose veins and oedema is the substantial pain expe
- Interventions in the management of serum lipids for preventing stroke recurrence
Cochrane Systematic Reviews, 8-Jul-2009
Studies have shown that interventions which reduce total and low-density lipoprotein cholesterol levels also reduce coronary heart disease (CHD) and stroke events in those with a history of CHD. However, it is uncertain whether treatment to alter choleste
- Interventions to improve adherence to lipid‐lowering medication
Cochrane Systematic Reviews, 21-Dec-2016
Lipid-lowering drugs are widely underused, despite strong evidence indicating they improve cardiovascular end points. Poor patient adherence to a medication regimen can affect the success of lipid-lowering treatment.
- Interventions to promote patient utilisation of cardiac rehabilitation
Cochrane Systematic Reviews, 1-Feb-2019
International clinical practice guidelines routinely recommend that cardiac patients participate in rehabilitation programmes for comprehensive secondary prevention. However, data show that only a small proportion of these patients utilise rehabilitation.
- Interventions used to improve control of blood pressure in patients with hypertension
Cochrane Systematic Reviews, 17-Mar-2010
Patients with high blood pressure (hypertension) in the community frequently fail to meet treatment goals - a condition labelled as "uncontrolled" hypertension. The optimal way to organize and deliver care to hypertensive patients has not been clearly ide
- Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
Cochrane Systematic Reviews, 27-Mar-2015
Intra-aortic balloon pump counterpulsation (IABP) is currently the most commonly used mechanical assist device for patients with cardiogenic shock due to acute myocardial infarction. Although there has been only limited evidence from randomised controlled
- Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
Cochrane Systematic Reviews, 30-Oct-2019
Pleural infection, including parapneumonic effusions and thoracic empyema, may complicate lower respiratory tract infections. Standard treatment of these collections in adults involves antibiotic therapy, effective drainage of infected fluid and surgical
- Intravascular brachytherapy for peripheral vascular disease
Cochrane Systematic Reviews, 8-Jan-2014
Interventional treatment of arteries that are narrowed and obstructed by atherosclerosis involves either bypassing the blockage using a graft; widening the artery from the inside with a balloon, a procedure known as percutaneous transluminal angioplasty (
- Intravenous fluids for abdominal aortic surgery
Cochrane Systematic Reviews, 20-Jan-2010
Surgery on the abdominal aorta to treat aneurysms or occlusive disease is a major undertaking which requires intensive physiological support and fluid management. Blood products are often used but the main fluid replacement is with crystalloids or colloid
- Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Cochrane Systematic Reviews, 31-Jan-2013
Wegener's granulomatosis (WG) is a necrotizing small-vessel vasculitis that can affect any organ in the body but mainly affects the upper and lower respiratory tract, the kidneys, joints, skin and eyes. The current mainstay of remission induction therapy
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults
Cochrane Systematic Reviews, 19-Aug-2020
This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace.
- Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Cochrane Systematic Reviews, 20-Oct-2003
Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. The coronary arteries supplying the heart can be damaged in Kawasaki disease. The principal advantage of timely diagnosis is the potential to prevent t
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Cochrane Systematic Reviews, 16-Sep-2013
Mortality from sepsis and septic shock remains high. Results of trials on intravenous immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is an update of a Cochrane review that was originally published in 1999 and updated i
- Intravenous naftidrofuryl for critical limb ischaemia
Cochrane Systematic Reviews, 11-Jul-2012
Peripheral arterial disease affects five per cent of men and women by late middle age. Approximately 25% of those affected will develop critical limb ischaemia (rest pain, ulceration and gangrene) within five years. Naftidrofuryl is a vasoactive drug whic
- Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease
Cochrane Systematic Reviews, 7-Sep-2011
Lung disease in preterm infants is often complicated with lung edema.
- Intraventricular streptokinase after intraventricular hemorrhage in newborn infants
Cochrane Systematic Reviews, 17-Oct-2007
Hydrocephalus following intraventricular hemorrhage (IVH) is still one of the most serious complications of premature birth. Ventriculoperitoneal shunt surgery cannot be carried out early and permanent dependence on a shunt is associated with several seri
- Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
Cochrane Systematic Reviews, 27-Apr-1998
Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have Raynaud's phenomenon (RP). One of the possible treatment op
